USA jobs

Jobs report: U.S. payrolls grew by 261,000 in October, unemployment rate rises to 3.7% – Yahoo Finance

The U.S. economy added more jobs than expected in October even as the Federal Reserve pressed on with the central bank's most aggressive monetary tightening campaign in decades.
Here are the highlights from the Labor Department's monthly jobs report released Friday, compared to consensus estimates from Bloomberg:
Non-farm payrolls: +261,000 vs. +195,000 expected
Unemployment rate: 3.7% vs. 3.6% expected
Average hourly earnings, month-over-month: +0.4% vs. +0.3% expected
Average hourly earnings, year-over-year: +4.7% vs. +4.7% expected
September’s payroll reading was also upwardly revised to 315,000 from 263,000 previously reported.
Employment data has moderated in recent months, but hiring remained strong in October despite efforts by the Federal Reserve to tamp down an extraordinarily tight labor market that has placed upward pressure on wages and contributed to decades-high inflation.
"The bottom line here is that the labor market is softening, but has not yet reached the point where the data are screaming at the Fed to stop tightening," Pantheon Macroeconomics Chief Economist Ian Shepherdson wrote in a note. "But if these trends continue, as we expect, markets will start to push the Fed — and especially Chair Powell — to rethink the idea of continued hikes next year."
Average hourly earnings rose 0.4% over the month, higher than the prior reading and Wall Street expectations. On an annual basis, wages held at 4.7%, on par with estimates.
Friday's figure effectively serves as a catalyst for Fed policymakers to proceed with further rate hikes, particularly after messaging from Fed Chair Jerome Powell on Wednesday that indicated slight moderations in the data were not enough for a pause on increases given the tight labor conditions.
“Although job vacancies have moved below their highs and the pace of job gains has slowed from earlier in the year, the labor market continues to be out of balance, with demand substantially exceeding the supply of available workers,” Powell said on Wednesday when addressing reporters after the FOMC delivered another 0.75% rate increase.
The labor force participation rate in ticked down slightly last month to 62.2% from 62.3% the prior month.
At the industry level, the largest gains were seen across health care, professional and technical services, and manufacturing, the Labor Department said in its release.
Jobs in health care rose by 53,000 after last month's gain brought the industry back to its February 2020 level. Employment in the sector has increased by an average of 47,000 per month so far in 2022, compared to 9,000 per month last year.
The manufacturing sector added 32,000 jobs in October, with gains concentrated across durable goods industries. The industry has seen an average increase of 37,000 jobs per month this year so far, higher than 2021's monthly average of 30,000.
Leisure and hospitality, one of the sectors hardest hit by the pandemic, continued its recovery, with 35,000 jobs added during the month. However, the gain was only a fraction of September's 83,000 increase and the monthly average for the industry this year of 78,000 jobs.
And although overall hiring has held up in the sector and the broader labor market has completed its COVID recovery, employment in leisure and hospitality remains 1.1 million jobs, or 6.5% below its February 2020, pre-pandemic level.
Overall, while economic data has shown resilience in the labor market, Corporate America has been on a layoff frenzy in recent weeks over concerns about the macroeconomic backdrop – with the a large share of hiring freezes and job cuts announced by technology companies.
Lyft (LYFT) said on Thursday that it would trim 13% of its staff, or around 683 people, while Amazon (AMZN) reported a pause on corporate hiring after halting hiring in its retail division last month.
Meanwhile, Apple (AAPL) has also suspended hiring for jobs outside of its research and development, Bloomberg reported earlier this week.

Alexandra Semenova is a reporter for Yahoo Finance. Follow her on Twitter @alexandraandnyc
Click here for the latest economic news and economic indicators to help you in your investing decisions
Read the latest financial and business news from Yahoo Finance
Download the Yahoo Finance app for Apple or Android
Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube
The memory giant rose on reports that China may be throwing in the towel on subsidizing competitors.
Buffett's company, Berkshire Hathaway, is much more invested in the tech sector than it used to be.
The current rate is good, but if you hold off until just before the next change, it could be even better.
The On-Balance-Volume (OBV) line shows some slight improvement from late September. The Moving Average Convergence Divergence (MACD) oscillator is bullish. The weekly OBV line has stayed steady but the MACD oscillator is now above the zero line and bullish.
Yahoo Finance Live anchors discuss GE HealthCare completing its spin-off from General Electric.
As 2023 starts gearing up for the long haul, Wall Street is still taking a bearish view of the markets. We’re still dealing with the same headwinds, a combination of stubbornly high inflation, rapidly rising interest rates, gloomy economic indicators, the continuing war in Ukraine, uncertainty over China’s lockdown policies, a supply chain that is only slowly unsnarling itself… the list can go on. But despite the grim outlook right now, there are still some signals that give reasons for longer-t
The bear run of 2022 was brutal on stock investors, in fact, it was the worst market year since the Great Recession of 2008. But – some of the Street’s strategists are predicting that this year has a recovery, or at least a partial rebound, in store. Even though the S&P 500 lost nearly 20% last year, inflation is still running at more than 7% annualized, and the Federal Reserve has bumped interest rates up to 4.25% in response, John Stoltzfus, Oppenheimer Asset Management chief investment strate
The über-rich are keeping their powder dry in the new year, a poll of ultra-high-net-worth investors found. Then they'll "pounce."
Yahoo Finance Live breaks down analyst concerns in Microsoft's Azure cloud unit, also commenting on the tech company's partnership with ChatGPT.
No Fed officials thought it’d be appropriate to begin cutting rates in 2023, as members thought that that price pressures could prove to be more persistent than anticipated with the job market remaining so strong for longer than anticipated, according to internal discussions of Fed officials at their policy meeting three weeks ago.
The cuts focused on the company’s corporate staff exceed an earlier projection and represent about 5% of the company’s corporate workforce.
For Citi customers with a sizable sum on hand, opening a new savings account can deliver just that — but, of course, not without significant hurdles. Like many bank accounts these days, the Citi® Savings Account comes with the promise of a hefty sign-up bonus — up to $3,500 — for simply opening a new account and “completing required activities.” Chanelle Bessette, banking specialist at NerdWallet, says offerings like these, albeit eye-catching at first glance, show just why it’s critical to read the fine print.
Amazon will eliminate “just over 18,000 roles” at the company, CEO Andy Jassy wrote in a memo to staffers Wednesday, well more than previously expected by the ecommerce giant. The layoffs will occur across “several teams” but the majority of job cuts are in the Amazon Stores group and its People, Experience and Technology (PXT) […]
Shares of telecom giant Verizon (NYSE: VZ) were rising today, up as much as 3.3% before settling into a 2.5% gain on the day. While the markets were broadly positive, Verizon's outsized gains were likely due to its CEO's appearance at a Citigroup telecom and technology conference today, during which CEO Hans Vestberg had positive things to say about the recently concluded fourth quarter. Without giving too many details, Vestberg stated that the company saw positive net additions in the fourth quarter, and that store traffic had increased compared with prior periods.
The big market headline last year has been the steady fall in stocks. The S&P 500 tumbled 19% for 2022, and the NASDAQ has fallen a disastrous 33%. And while recent data shows that there may be some hope on the inflation front, there may still be storm clouds massing for this year’s stock market. In times like these, it’s natural to turn to the high-yield dividend payers. These stocks offer the twin advantages of a steady income stream through regular, reliable dividend payments – and dividend y
After releasing topline late-stage clinical trial data on its drugs effect on a set of precancerous conditions, a longtime Bay Area biotech said it plans to raise $175 million through a stock sale. Geron Corp. (NASDAQ: GERN) said early Wednesday that its drug, called imetelstat, met the primary efficacy goal in a Phase III study in certain patients with myelodysplastic syndromes, or MDS. The company said it will submit the data to the Food and Drug Administration as it asks the agency this year to approve the drug.
(Bloomberg) — Markets aren’t prepared for how far US central bankers are willing to go to tame the hottest inflation in a generation, according to Morgan Stanley Investment Management’s Jim Caron.Most Read from BloombergIf You Have Student Loans, Mark These Dates on Your CalendarWhy Conservatives Are Blocking McCarthy as Speaker — and Throwing Congress Into ChaosFed Affirms Inflation Resolve, Pushes Back Against Rate-Cut BetsShopify Tells Employees to Just Say No to MeetingsEven though Federal
The deal comes shortly after Boeing lost its bid for a contract that would have been worth billions of dollars to the aerospace company and driven significant growth at the Ridley Park campus.
Question: I was a victim of FOMO during the housing market craziness and bought a house for $200,000 over the asking price. Since it’s a rental property, if you sell at a loss, you may be able to write off some of the loss on the property sale for tax purposes.
A kidney disease treatment from Vera lagged rivals from Chinook and Otsuka, analysts said Wednesday as the biotech stock plummeted.


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button